Andy Guinigundo: Great round up of SABCS studies by Matthew Kurian at the Immunotherapy and Precision Oncology Conference
Andy Guinigundo, Director of Precision Oncology at Cincinnati Cancer Advisors, shared a post on LinkedIn:
“St. Elizabeth Healthcare oncologist Matthew Kurian gave a great round up of the most intriguing studies from SABCS including Ember-3, Patina, and Destiny Breast 06 at Innovative Healthcare Institute Immunotherapy and Precision Oncology Forum.”
Matthew Kurian, Physician at St. Elizabeth Healthcare and Assistant Professor of Medicine at the University of Kentucky College of Medicine, shared this post adding:
“Had a fantastic time yesterday speaking about the latest innovations in breast cancer at Innovative Healthcare Institute’s Immunotherapy and Precision Oncology (IPOF) Conference! Proud to represent St. Elizabeth Healthcare with Ivan Bedoya!
Heard from leaders and giants in the field like Aung Naing from MD Anderson Cancer Center and Christian Rolfo,and David Carbone from Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute, discussing issues like ctDNA use, targeted treatments, and immunotherapy benefits across tumor types was very insightful!
Kudos Cincinnati Cancer Advisors Andy Guinigundo, Abdul Rahman Jazieh, and Philip D. Leming on continuing to educate our Cincinnati/NKY oncology community!”
More posts featuring Matthew Kurian.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023